Project Grant R01AA033092
- The National Institute on Alcohol Abuse and Alcoholism awarded Duke University $191,443 under the Alcohol Research Programs (CFDA 93.273) on May 1, 2026, to conduct a five-year study examining the proximal relationship between alcohol misuse and suicidal thoughts and behaviors among youth, with focus on executive functioning deficits and interpersonal stress as potential mechanisms of risk. The research will enroll 90 youth participants presenting to two emergency departments in Durham, North...
- The National Institute on Alcohol Abuse and Alcoholism awarded Virginia Commonwealth University $739,964 on September 11, 2025, under the Alcohol Research Programs (CFDA 93.273) to support research dissecting the co-occurrence of alcohol use and problems with suicidal thoughts and behaviors through genetic liability and neurocognitive mechanisms. The research explores aggregate genetic liability and neurocognitive mechanisms underlying the co-occurrence of alcohol use disorders and suicidal...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Rhode Island $1,403,716 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to examine transactional relationships between sensor-derived alcohol use data and acute suicide risk during community re-entry following residential alcohol use disorder treatment. The research uses ecological momentary assessment and transdermal alcohol sensor technology (BACtrack Skyn) to assess time-varying,...
- The National Institute on Alcohol Abuse and Alcoholism awarded Public Health Institute $1,291,065 under the Alcohol Research Programs (CFDA 93.273) on September 20, 2025. The project conducts analyses of alcohol-related mortality in the United States with emphasis on spirits consumption, examining mortality rate relationships with beverage-specific per capita consumption and policy interventions. The work addresses mortality trends that have increased dramatically since 1999 and particularly...
- The National Institute on Alcohol Abuse and Alcoholism awarded Weill Medical College of Cornell University $591,468 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct longitudinal neuroimaging analysis identifying neural risk factors for drinking onset in young adulthood. The recipient will apply machine learning analysis to nine years of longitudinal neuroimaging, behavioral, and neuropsychological data from 466 adolescents (baseline ages 12–18 years) enrolled in...
- The National Institute on Alcohol Abuse and Alcoholism awarded Duke University $2,725,992 under the Alcohol Research Programs (CFDA 93.273) on September 1, 2026, to assess the impact of three employer-sponsored strategies on alcohol use disorder (AUD) detection, treatment, and health outcomes among working-age adults with private insurance. The project will evaluate whether expanding clinician provider networks, reducing out-of-pocket financial barriers to care, and implementing...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Research Foundation For The State University Of New York $628,150 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct the Honoring and Examining Alcohol Recovery (HEAR) Study, a longitudinal examination of recovery capital and its association with recovery outcomes. The award funds research to advance understanding of recovery capital—the social, physical, human, and cultural resources that...
- The National Institute on Alcohol Abuse and Alcoholism awarded Loyola University of Chicago Health Sciences Campus $115,500 on August 17, 2026, under the Alcohol Research Programs (CFDA 93.273) to identify leading causes and pathways of death in alcoholic acute respiratory distress syndrome (ARDS) patients through computational analysis of clinical trial datasets. The recipient will conduct a retrospective cohort study validating findings across five NIH-funded, multicenter, randomized,...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Research Foundation for the State University of New York $493,145 on September 25, 2025, under the Alcohol Research Programs (CFDA 93.273) to examine emotion regulation strategy use in an outpatient treatment program for adolescents with co-occurring alcohol use disorder and psychiatric diagnoses. The research employs ecological momentary assessment (EMA) to study how adolescents aged 13–18 develop and deploy emotion regulation...
- The National Institute on Alcohol Abuse and Alcoholism awarded Icahn School of Medicine at Mount Sinai $3.112 million on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate histone acetylation and synaptic mechanisms underlying resilience to compulsive-like alcohol drinking. The recipient will conduct research on the role of SIRT7, a histone deacetylase, in D1-type medium spiny neurons within the dorsomedial striatum, examining how epigenetic changes and synaptic...
The National Institute on Alcohol Abuse and Alcoholism awarded New York University School of Medicine $2.920164 million on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and evaluate a precision prevention approach for identifying and addressing behavioral health treatment gaps that drive suicide risk. The project will identify subgroups at highest risk of suicidal thoughts and behaviors, characterize which combinations of mental and substance use disorders place distinct populations at greater suicide risk, and determine which evidence-based interventions most effectively expand treatment uptake for each subgroup. The study will examine how co-occurring alcohol use disorder with depression, untreated opioid use disorder, and other mental and substance use disorder patterns differentially mediate suicide risk across demographic and clinical subgroups, and will assess which barriers to care and which interventions—including health insurance enrollment outreach, telehealth, stigma reduction campaigns, and mental health service navigation—are most critical for distinct populations. Work will be performed in New York, New York, with a period of performance from August 1, 2026, through July 31, 2030. This is a project grant, which the Alcohol Research Programs supports for projects recommended for approval by the National Advisory Council on Alcohol Abuse and Alcoholism, typically not exceeding five years in duration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.9m | 8/6/26 |